Type 2 diabetes and its associated comorbidities are growing more prevalent, and the complexity of optimizing
glycaemic control is increasing, especially in the frontlines of patient care. In many countries, most patients with
type 2 diabetes are managed in a primary care setting. However, primary healthcare professionals face the
challenge of the growing plethora of available treatment options for managing hyperglycemia, leading to
difficulty in making treatment decisions and contributing to the treatment and therapeutic inertia. This position
statement offers a simple and patient-centered clinical decision-making model with practical treatment recommendations
that can be widely implemented by primary care clinicians worldwide through shared-decision
conversations with their patients. It highlights the importance of managing cardiovascular disease and
elevated cardiovascular risk in people with type 2 diabetes and aims to provide innovative risk stratification and
treatment strategies that connect patients with the most effective care.
